News Focus
News Focus
Followers 46
Posts 3496
Boards Moderated 0
Alias Born 02/08/2014

Re: None

Wednesday, 11/19/2025 12:15:05 PM

Wednesday, November 19, 2025 12:15:05 PM

Post# of 445032
In reading the transcript of the call, it reads like Nasrat is confident tht OxyContin ER is coming to the market in the next 6 months, at least it does to me at this moment.

Here is clearly references Oxy then states it is coming to the market.

Then we have OxyContin ER, which is under review by FDA. So now you have the pipeline populated by something the FDA is reviewing that's going to become in the market.



Here he seems to say that Oxy could open for everyone in the first half of the year. Everyone that is that has the approval.

Now the government is going to take charge of Purdue, and they're going to be in charge of OxyContin. Are they going to open the door for all the generic companies to get in? Or are they going to insist on 3Month stay? I don't know. This is an uncharted territory. I've never seen the government take over a company before in the pharmaceuticals. So we'll see what they're going to do. If they do away with it, then everybody gets in. If they don't, we'll all have to wait 3 months.



If that is true that is additional income that a company debating M&A can count on in the relative near term.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News